Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3643711
Max Phase: Preclinical
Molecular Formula: C19H21F6NO4
Molecular Weight: 441.37
Molecule Type: Small molecule
Associated Items:
ID: ALA3643711
Max Phase: Preclinical
Molecular Formula: C19H21F6NO4
Molecular Weight: 441.37
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C1N(c2ccc(OCC(F)(F)F)cc2)CC[C@@]12CC[C@@H](O)[C@H](OCC(F)(F)F)C2
Standard InChI: InChI=1S/C19H21F6NO4/c20-18(21,22)10-29-13-3-1-12(2-4-13)26-8-7-17(16(26)28)6-5-14(27)15(9-17)30-11-19(23,24)25/h1-4,14-15,27H,5-11H2/t14-,15-,17-/m1/s1
Standard InChI Key: ZYNDZSWTZGGJGC-BFYDXBDKSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 441.37 | Molecular Weight (Monoisotopic): 441.1375 | AlogP: 3.84 | #Rotatable Bonds: 5 |
Polar Surface Area: 59.00 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 3.21 | CX LogD: 3.21 |
Aromatic Rings: 1 | Heavy Atoms: 30 | QED Weighted: 0.71 | Np Likeness Score: -0.16 |
1. (2014) SEC-hydroxycyclohexyl derivatives, |
Source(1):